Guideline changes extend HPV DNA self-collection option to test of cure
The updated cervical cancer screening recommendations will come into effect in April.
Patients successfully treated for high-grade squamous intraepithelial lesions can now be given the option of HPV self-collection under revised test-of-cure advice.
Under changes to the guidelines, from April this year people treated for high-grade squamous intraepithelial lesions can be managed with annual HPV tests as test of cure rather than co-testing with liquid-based cytology (LBC).
